What is the recommended management for acute phenytoin overdose, including decontamination, airway protection, seizure control, cardiac monitoring, electrolyte correction, and supportive care?

Management of Phenytoin Toxicity

The treatment of phenytoin toxicity is primarily supportive care with no specific antidote, focusing on airway protection, cardiovascular monitoring, electrolyte correction, and prevention of injury from neurological symptoms. 1, 2

Initial Assessment and Stabilization

Airway and Respiratory Management

• Secure the airway immediately in patients with depressed consciousness or coma, as severe intoxication can progress to respiratory depression and death 1, 2
• Ensure adequate oxygenation throughout the treatment course 3
• Intubation may be necessary in severely obtunded or comatose patients, particularly when phenytoin levels exceed 40-50 mcg/mL 1, 2

Cardiovascular Monitoring

• Monitor vital signs continuously, particularly for hypotension and cardiac arrhythmias, though these are rare with oral overdose and more common with IV administration 4, 3
• Perform continuous ECG monitoring to detect bradycardia, arrhythmias, or heart block 5
• Do NOT administer lidocaine or additional phenytoin to treat toxicity-induced arrhythmias, as this can worsen the clinical picture 3

Electrolyte Management

• Correct electrolyte abnormalities, particularly ensuring serum potassium is greater than 4 mM/L to prevent cardiac complications 3
• Monitor and correct other electrolyte disturbances as they arise 3

Gastrointestinal Decontamination

Activated Charcoal Considerations

• Consider single-dose activated charcoal only if the patient presents within 1-2 hours of ingestion and can protect their airway 2
• The role of multiple-dose activated charcoal remains controversial—experimental studies show increased clearance rates, but this has not translated into proven clinical benefit 2
• There is no evidence that any method of gastrointestinal decontamination improves overall outcome 2

Seizure Management

If Seizures Occur Despite Phenytoin Toxicity

• Use benzodiazepines as first-line therapy for seizures occurring in the context of phenytoin toxicity 6
• If seizures persist after benzodiazepines, consider alternative anticonvulsants such as valproate, levetiracetam, or phenobarbital—do NOT give additional phenytoin 6, 3
• Valproate may be particularly effective, with 79% seizure control as second-line therapy versus 25% with phenytoin 6

Supportive Care and Symptom Management

Neurological Symptom Management

• Prevent injuries from confusion, ataxia, and impaired coordination by implementing fall precautions and close observation 2, 7
• Expect neurological symptoms to correlate with plasma levels: nystagmus at 20 mcg/mL, ataxia at 30 mcg/mL, dysarthria and lethargy above 40 mcg/mL 1
• Manage nausea and vomiting with antiemetics as needed 2

Duration of Symptoms

• Anticipate prolonged hospitalization due to zero-order pharmacokinetics in overdose, which dramatically increases the half-life and extends symptom duration 2
• Natural elimination can take days to weeks depending on the degree of overdose 2, 7

Enhanced Elimination Techniques

Standard Approach

• There is no evidence that invasive methods of enhanced elimination (hemodialysis, hemoperfusion, plasmapheresis) improve clinical outcomes in most cases 2
• Phenytoin is highly protein-bound (90-95%), making standard dialysis largely ineffective 2, 8

Special Circumstances for Extracorporeal Removal

• Consider hemoperfusion or high-flux hemodialysis with high cut-off dialyzers only in severe, life-threatening cases with persistent coma and toxic levels despite supportive care 9, 10
• In hypoalbuminemic patients with high free phenytoin fractions, high-flux dialysis may be more effective as an adjuvant to hemoperfusion 9
• One case report demonstrated 28.5% reduction in phenytoin levels over 8 hours using a high cut-off dialyzer, with phenytoin half-life decreasing from 1109.8 hours to 18.5 hours during dialysis 10
• These interventions should be reserved for exceptional cases where the patient remains comatose for many days with persistently toxic levels 9, 10

Special Populations

Neonates and High-Risk Patients

• Neonates have increased risk of toxicity due to decreased protein binding 3
• Patients with hypoalbuminemia will have higher free (active) phenytoin fractions even with "normal" total levels 9

Drug Interactions

• Be aware that drug interactions, particularly with clarithromycin, erythromycin, and other medications, can precipitate phenytoin toxicity 3
• Enzyme-inducing drugs like phenobarbital or carbamazepine can shorten phenytoin half-life, while enzyme inhibitors can increase levels 8

Clinical Pitfalls to Avoid

• Never administer additional phenytoin or lidocaine for arrhythmias in phenytoin toxicity 3
• Do not rely on total phenytoin levels alone in hypoalbuminemic patients—free phenytoin levels are more clinically relevant 9
• Avoid premature discharge, as zero-order kinetics can cause unexpectedly prolonged toxicity 2
• Deaths from phenytoin ingestion alone are unlikely, but respiratory and circulatory depression require aggressive supportive care 1, 2
• Consider co-ingestion of other CNS depressants including alcohol in acute overdose scenarios 1